Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial
易普利姆玛
无容量
医学
肺癌
内科学
肿瘤科
化疗
癌症
打开标签
临床试验
免疫疗法
作者
Martin Reck,Michael Schenker,Ki Hyeong Lee,Mariano Provencio,Makoto Nishio,Krzysztof Leśniewski-Kmak,Randeep Sangha,Samreen Ahmed,Judith Raimbourg,Kynan Feeney,R. Corre,Fábio Franke,Eduardo Richardet,John R. Penrod,Yong Yuan,Faith E. Nathan,Prabhu Bhagavatheeswaran,Michael DeRosa,Fiona Taylor,Rachael Lawrance
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
Ethan
郭竞阳
AllRightReserved
嘻嘻哈哈
愔愔
贪玩的秋柔
Criminology34
OsamaKareem
无极微光
YifanWang
arbitmomo
Tong
Moonpie
Nexus
fearless
淡然的新晴
嘉心糖
mmyhn
小宋
皖公网安备34019202002308
